FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Apotex Fluticasone propionate Nasal Spray Recall

Fluticasone propionate Nasal Spray, USP, 50 mcg, packaged in 50 mcg per spray 120 Meter…

Apotex Inc. · North York, N/A

Risk level
Class II
Reported by FDA
Jun 13, 2018
Recall ID
D-0841-2018
Check your lot numberHow we source this data

Summary

Apotex recalled Fluticasone propionate Nasal Spray starting May 31, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0841-2018 on Jun 13, 2018. Reason: Presence of foreign substance: glass particles. Status: Terminated.

Why it was recalled

Presence of foreign substance: glass particles

Product description

Fluticasone propionate Nasal Spray, USP, 50 mcg, packaged in 50 mcg per spray 120 Metered Sprays bottles, 16 g net fill weight, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, FL 33326, NDC 60505-0829-1

Lot numbers, UPCs & expiration codes

Lot: NJ4501 Exp. 07/2020

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0841-2018
Classification
Class II
Status
Terminated
Recall initiated
May 31, 2018
FDA report date
Jun 13, 2018
Quantity
Unknown
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Inc.

Original FDA data

Every field from FDA enforcement report D-0841-2018, exactly as published.

Show all FDA fields
City
North York
Status
Terminated
Country
Canada
Event ID
80202
Address
150 Signet Dr
Code information
Lot: NJ4501 Exp. 07/2020
Report date
Jun 13, 2018
Product type
Drugs
Recall number
D-0841-2018
Classification
Class II
Recalling firm
Apotex Inc.
Product quantity
Unknown
Termination date
Sep 28, 2022
Reason for recall
Presence of foreign substance: glass particles
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fluticasone propionate Nasal Spray, USP, 50 mcg, packaged in 50 mcg per spray 120 Metered Sprays bottles, 16 g net fill weight, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, FL 33326, NDC 60505-0829-1
Distribution pattern
Nationwide
Recall initiation date
May 31, 2018
Initial firm notification
Press Release
Center classification date
Jun 6, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0841-2018, published Jun 13, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls